Avalon GloboCare (ALBT) Competitors $3.66 +0.19 (+5.48%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$3.69 +0.03 (+0.85%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends ALBT vs. NRSN, HCWB, FLGC, SNSE, IMNN, BGXX, AIM, HOTH, CRVO, and WENAShould you be buying Avalon GloboCare stock or one of its competitors? The main competitors of Avalon GloboCare include NeuroSense Therapeutics (NRSN), HCW Biologics (HCWB), Flora Growth (FLGC), Sensei Biotherapeutics (SNSE), Imunon (IMNN), Bright Green (BGXX), AIM ImmunoTech (AIM), Hoth Therapeutics (HOTH), CervoMed (CRVO), and ANEW Medical (WENA). These companies are all part of the "pharmaceutical products" industry. Avalon GloboCare vs. NeuroSense Therapeutics HCW Biologics Flora Growth Sensei Biotherapeutics Imunon Bright Green AIM ImmunoTech Hoth Therapeutics CervoMed ANEW Medical NeuroSense Therapeutics (NASDAQ:NRSN) and Avalon GloboCare (NASDAQ:ALBT) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, community ranking, analyst recommendations, media sentiment, dividends and institutional ownership. Does the media refer more to NRSN or ALBT? In the previous week, NeuroSense Therapeutics' average media sentiment score of 0.00 equaled Avalon GloboCare'saverage media sentiment score. Company Overall Sentiment NeuroSense Therapeutics Neutral Avalon GloboCare Neutral Do analysts rate NRSN or ALBT? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroSense Therapeutics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Avalon GloboCare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is NRSN or ALBT more profitable? NeuroSense Therapeutics has a net margin of 0.00% compared to Avalon GloboCare's net margin of -1,125.59%. Company Net Margins Return on Equity Return on Assets NeuroSense TherapeuticsN/A N/A -590.79% Avalon GloboCare -1,125.59%N/A -73.69% Does the MarketBeat Community prefer NRSN or ALBT? NeuroSense Therapeutics received 2 more outperform votes than Avalon GloboCare when rated by MarketBeat users. CompanyUnderperformOutperformNeuroSense TherapeuticsOutperform Votes266.67% Underperform Votes133.33% Avalon GloboCareN/AN/A Which has more volatility & risk, NRSN or ALBT? NeuroSense Therapeutics has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Comparatively, Avalon GloboCare has a beta of 0.19, meaning that its stock price is 81% less volatile than the S&P 500. Which has higher earnings and valuation, NRSN or ALBT? NeuroSense Therapeutics has higher earnings, but lower revenue than Avalon GloboCare. NeuroSense Therapeutics is trading at a lower price-to-earnings ratio than Avalon GloboCare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroSense TherapeuticsN/AN/A-$11.28M-$0.64-1.70Avalon GloboCare$1.26M3.17-$16.71M-$19.96-0.18 Do institutionals & insiders have more ownership in NRSN or ALBT? 1.0% of NeuroSense Therapeutics shares are held by institutional investors. Comparatively, 1.4% of Avalon GloboCare shares are held by institutional investors. 27.4% of NeuroSense Therapeutics shares are held by company insiders. Comparatively, 37.3% of Avalon GloboCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryNeuroSense Therapeutics beats Avalon GloboCare on 6 of the 10 factors compared between the two stocks. Get Avalon GloboCare News Delivered to You Automatically Sign up to receive the latest news and ratings for ALBT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALBT vs. The Competition Export to ExcelMetricAvalon GloboCareBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$4M$2.96B$5.34B$9.11BDividend YieldN/A1.89%5.37%4.00%P/E RatioN/A16.4456.8413.06Price / Sales3.17288.031,275.3476.04Price / CashN/A189.5236.6132.89Price / Book-0.213.924.874.58Net Income-$16.71M-$40.99M$118.05M$224.84M7 Day Performance9.25%1.13%1.47%2.37%1 Month Performance7.02%-1.72%2.54%4.40%1 Year Performance-42.59%-2.23%25.37%20.10% Avalon GloboCare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALBTAvalon GloboCareN/A$3.66+5.5%N/A-42.6%$4M$1.26M0.005Positive NewsNRSNNeuroSense Therapeutics0.7079 of 5 stars$1.04-0.4%N/A+13.5%$14.16MN/A-1.2210HCWBHCW Biologics1.2038 of 5 stars$0.36-1.9%N/A-66.4%$13.77M$3.50M-0.3640FLGCFlora Growth2.1889 of 5 stars$0.93-3.2%$5.00+438.2%-43.5%$13.40M$64.15M0.00280SNSESensei Biotherapeutics4.3783 of 5 stars$0.53+3.5%$4.33+717.0%-33.1%$13.34MN/A-0.4540Gap DownIMNNImunon1.9827 of 5 stars$0.92+1.8%$20.50+2,137.7%+60.2%$13.28M$500,000.00-0.4830Short Interest ↑BGXXBright GreenN/A$0.07+1.0%N/A-68.7%$13.19MN/A-1.152Gap DownAIMAIM ImmunoTech1.8491 of 5 stars$0.20-4.7%$2.75+1,242.1%-49.1%$13.07M$190,000.00-0.4420HOTHHoth Therapeutics2.6882 of 5 stars$1.89-0.5%$4.00+111.6%+16.3%$13.05MN/A-1.434Gap UpCRVOCervoMed3.6112 of 5 stars$2.04-3.3%$42.00+1,958.8%-77.3%$12.59M$7.14M0.004News CoveragePositive NewsWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap Up Related Companies and Tools Related Companies NeuroSense Therapeutics Competitors HCW Biologics Competitors Flora Growth Competitors Sensei Biotherapeutics Competitors Imunon Competitors Bright Green Competitors AIM ImmunoTech Competitors Hoth Therapeutics Competitors CervoMed Competitors ANEW Medical Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ALBT) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avalon GloboCare Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avalon GloboCare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
